- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ABT
Recent news which mentions ABT
3 Great Dividend Stocks to Buy in October
October 08, 2022
From Motley Fool
Why DexCom Stock Popped on Friday, Even as the Market Crumbled
October 07, 2022
From Motley Fool
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
October 05, 2022
From InvestorPlace
3 Dividend Stocks to Buy In October and Hold Forever
October 05, 2022
From Motley Fool
Here's Why This Dividend King Is a Buy
October 01, 2022
From Motley Fool
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever
September 28, 2022
From Motley Fool
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
From Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Got $2,000? Invest In These 2 Perpetually Growing Stocks
September 26, 2022
From Motley Fool
2 Growth Stocks Down 14% to 28% to Buy and Hold Forever
September 26, 2022
From Motley Fool
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
September 26, 2022
From Benzinga
Is AbbVie a Buy?
September 24, 2022
From Motley Fool
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist.
September 23, 2022
From MarketWatch
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
From Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
September 22, 2022
Tickers
ABT
From Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
September 21, 2022
Tickers
ABT
From Benzinga
FDA Concludes Oversight Shortcomings After Infant Formula Internal Review
September 21, 2022
Tickers
ABT
From Benzinga
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
September 17, 2022
From Benzinga
3 Stocks You Can Keep Forever
September 17, 2022
From Motley Fool
Stock Market Sell-Off: 2 Reliable Dividend Stocks to Buy On the Dip
September 16, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
From InvestorPlace
Where to Invest $5,000 Right Now
September 14, 2022
From Motley Fool
3 Unstoppable Dividend Stocks to Buy in September
September 13, 2022
From Motley Fool
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the Market
September 12, 2022
From Motley Fool
3 Beaten-Down Stocks to Buy Right Now
September 11, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.